Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
10.58
-0.03 (-0.28%)
Aug 15, 2025, 10:11 AM - Market open
Daxor Market Cap
Daxor has a market cap or net worth of $52.50 million as of August 15, 2025. Its market cap has increased by 23.55% in one year.
Market Cap
52.50M
Enterprise Value
53.38M
1-Year Change
23.55%
Ranking
Category
Stock Price
$10.58
Market Cap Chart
Since September 3, 1985, Daxor's market cap has increased from $30.27M to $52.50M, an increase of 73.46%. That is a compound annual growth rate of 1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 54.73M | 47.05% |
| Dec 31, 2024 | 37.22M | -19.10% |
| Dec 29, 2023 | 46.01M | 17.82% |
| Dec 30, 2022 | 39.05M | -14.22% |
| Dec 31, 2021 | 45.52M | -6.35% |
| Dec 31, 2020 | 48.61M | 38.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 608.26B |
| Johnson & Johnson | 420.95B |
| AbbVie | 361.99B |
| UnitedHealth Group | 245.26B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.90B |